{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:50:23Z","timestamp":1764251423206},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1097\/tp.0000000000001435","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T17:05:59Z","timestamp":1470762359000},"page":"2404-2409","source":"Crossref","is-referenced-by-count":7,"title":["Fulminant Hepatic Failure as a Risk Factor for Cytomegalovirus Infection in Children Receiving Preemptive Therapy After Living Donor Liver Transplantation"],"prefix":"10.1097","volume":"100","author":[{"given":"Munehiro","family":"Furuichi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinari","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mureo","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Miyairi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-28-20210211","first-page":"294","article-title":"OKT3 and viral disease in pediatric liver transplant recipients","volume":"5","author":"Bowman","year":"1991","journal-title":"Clin Transplant"},{"key":"R2-28-20210211","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4254\/wjh.v6.i6.370","article-title":"Management of cytomegalovirus infection and disease in liver transplant recipients","volume":"6","author":"Bruminhent","year":"2014","journal-title":"World J Hepatol"},{"key":"R3-28-20210211","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.transproceed.2010.02.041","article-title":"The risk factors for cytomegalovirus syndrome and tissue-invasive cytomegalovirus disease in liver transplant recipients who have cytomegalovirus antigenemia","volume":"42","author":"Kim","year":"2010","journal-title":"Transplant Proc"},{"key":"R4-28-20210211","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/TP.0b013e31822d873d","article-title":"A universal preemptive therapy for cytomegalovirus infections in children after live-donor liver transplantation","volume":"92","author":"Saitoh","year":"2011","journal-title":"Transplantation"},{"key":"R5-28-20210211","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.trim.2010.06.013","article-title":"Preemptive therapy for cytomegalovirus based on real-time measurement of viral load in liver transplant recipients","volume":"23","author":"Sun","year":"2010","journal-title":"Transpl Immunol"},{"key":"R6-28-20210211","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/tid.12050","article-title":"Evaluation of risk factors for cytomegalovirus infection and disease occurring within 1 year of liver transplantation in high-risk patients","volume":"15","author":"Katsolis","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"R7-28-20210211","first-page":"CD005133","article-title":"Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients","volume":"2","author":"Owers","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-28-20210211","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"key":"R9-28-20210211","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/TP.0b013e31817889e4","article-title":"Prophylaxis followed by preemptive therapy versus preemptive therapy for prevention of human cytomegalovirus disease in pediatric patients","volume":"86","author":"Gerna","year":"2008","journal-title":"Transplantation"},{"key":"R10-28-20210211","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/cid\/cit945","article-title":"A direct and indirect comparison meta-analysis on the efficacy of cytomegalovirus preventive strategies in solid organ transplant","volume":"58","author":"Florescu","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R11-28-20210211","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/lt.20754","article-title":"Live Donor Liver Transplantation","volume":"12","author":"Florman","year":"2006","journal-title":"Liver Transpl"},{"key":"R12-28-20210211","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.4254\/wjh.v7.i11.1509","article-title":"Current developments in pediatric liver transplantation","volume":"7","author":"Hackl","year":"2015","journal-title":"World J Hepatol"},{"key":"R13-28-20210211","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00007890-199901150-00016","article-title":"Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients","volume":"67","author":"Humar","year":"1999","journal-title":"Transplantation"},{"key":"R14-28-20210211","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.transproceed.2011.03.076","article-title":"Liver transplantation for acute liver failure: the Hungarian experience","volume":"43","author":"Nemes","year":"2011","journal-title":"Transplant Proc"},{"key":"R15-28-20210211","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1399-3046.2007.00718.x","article-title":"Living donor liver transplantation for acute liver failure in infants: the impact of unknown etiology","volume":"12","author":"Sakamoto","year":"2008","journal-title":"Pediatr Transplant"},{"key":"R16-28-20210211","first-page":"658","article-title":"Hepatology.","volume":"25","year":"1997","journal-title":""},{"key":"R17-28-20210211","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.3748\/wjg.v20.i31.10658","article-title":"Cytomegalovirus infection in liver transplant recipients: updates on clinical management","volume":"20","author":"Marcelin","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R18-28-20210211","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/ajt.12755","article-title":"Current prevention strategies against cytomegalovirus in the Studies in Pediatric Liver Transplantation (SPLIT) centers","volume":"14","author":"Danziger-Isakov","year":"2014","journal-title":"Am J Transplant"},{"key":"R19-28-20210211","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.TP.0000145989.22373.03","article-title":"Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxis","volume":"78","author":"Limaye","year":"2004","journal-title":"Transplantation"},{"key":"R20-28-20210211","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/TP.0b013e3181a19cda","article-title":"A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients","volume":"87","author":"Madan","year":"2009","journal-title":"Transplantation"},{"key":"R21-28-20210211","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/00007890-200109270-00020","article-title":"Risk factors for chronic rejection after pediatric liver transplantation","volume":"72","author":"Gupta","year":"2001","journal-title":"Transplantation"},{"key":"R22-28-20210211","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/ajt.13044","article-title":"Universal prophylaxis or preemptive strategy for cytomegalovirus disease after liver transplantation: a systematic review and meta-analysis","volume":"15","author":"Mumtaz","year":"2015","journal-title":"Am J Transplant"},{"key":"R23-28-20210211","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/tid.12226","article-title":"Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+\/R\u2212): experience from the RESITRA-REIPI cohort","volume":"16","author":"Meije","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"R24-28-20210211","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/jmv.22232","article-title":"Comparison of a UL111a real-time PCR and pp65 antigenemia for the detection of cytomegalovirus","volume":"83","author":"Beckmann","year":"2011","journal-title":"J Med Virol"},{"key":"R25-28-20210211","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.transproceed.2007.01.088","article-title":"Real-time PCR assay compared with antigenemia assay for detecting cytomegalovirus infection in kidney transplant recipients","volume":"39","author":"Kim","year":"2007","journal-title":"Transplant Proc"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000001435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:25:39Z","timestamp":1620977139000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201611000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000001435","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}